XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating Activities:    
Net loss $ (5,578,533) $ (10,525,014)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 371,653 1,376,201
Share based compensation 79,737 217,838
Realized loss (gain) on sale of assets (1,205,663) 0
Amortization of financing costs to interest expense 35,164 80,089
Write down of previously capitalized inventory 363,758 0
Non-cash interest expense 575,015 54,379
Amortization of debt discount 1,474,135 1,923,705
Change in fair value of derivatives and gain/loss on extinguishment of liabilities, net (673,078) 773,236
Inducement conversion costs 407,974 0
Bad debt expense 4,082 16,993
Changes in operating assets and liabilities:    
Accounts receivable 533,822 453,454
Inventories 899,915 119,889
Prepaid expenses and other current assets 394,550 (318,848)
Accounts payable (249,691) (183,326)
Accrued expenses 56,721 298,153
Accrued litigation settlement (143,266) (130,687)
Warranty reserve (7,489) (18,351)
Net cash used in operating activities (2,661,194) (5,862,289)
Investing Activities:    
Proceeds from the sale of assets 150,000 0
Patent activity costs (19,275) (66,470)
Net cash provided by/(used in) investing activities 130,725 (66,470)
Financing Activities:    
Payment of debt financing costs (42,500) (25,000)
Repayment of debt 0 (78,282)
Proceeds from promissory note 2,340,000 0
Proceeds from Committed Equity Line 0 1,056,147
Proceeds from issuance of stock and warrants 150,000 5,000,000
Net cash provided by financing activities 2,447,500 5,952,865
Net change in cash and cash equivalents (82,969) 24,106
Cash and cash equivalents at beginning of period 130,946 326,217
Cash and cash equivalents at end of period 47,977 350,323
Supplemental Cash Flow Information:    
Cash paid for interest 20,415 139,090
Non-Cash Transactions:    
Non-cash conversions of preferred stock and convertible notes to equity 1,699,731 3,441,115
Make-whole provision on convertible preferred stock 257,152 0
Accounts payable converted to notes payable $ 1,172,026 $ 0